FBN1 and colorectal carcinoma: We had found that FBN1 methylation incidence of control, adenoma or polyp patients, and CRC in tissue was 2.7%, 69.4%, and 79.1%, respectively, and that in feces it was 10.8%, 50.7%, and 74.6%, respectively.